su li - Net Worth and Insider Trading
su li Net Worth
The estimated net worth of su li is at least $306,251 dollars as of 2025-03-28. su li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 12,100 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $306,251. Details can be seen in su li's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that su li has not made any transactions after 2022-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of su li
su li Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, su li owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .
Click here to see the complete history of su li’s form 4 insider trades.
Insider Ownership Summary of su li
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-13 | senior management |
su li Latest Holdings Summary
su li currently owns a total of 1 stock. su li owns 12,100 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 13, 2022, with a value of $306,251.
Latest Holdings of su li
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-13 | 12,100 | 25.31 | 306,251 |
Holding Weightings of su li
su li Form 4 Trading Tracker
According to the SEC Form 4 filings, su li has made a total of 4 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the acquisition of 2,000 shares on September 13, 2022, which cost su li around $69,020.
Insider Trading History of su li
- 1
su li Trading Performance
GuruFocus tracks the stock performance after each of su li's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by su li is 5.31%. GuruFocus also compares su li's trading performance to market benchmark return within the same time period. The performance of stocks bought by su li within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how su li's insider trading performs compared to the benchmark.
Performance of su li
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15 | | | | | |
| Relative Return to S&P 500(%) | -6.28 | | | | | |
su li Ownership Network
Ownership Network List of su li
Ownership Network Relation of su li
su li Owned Company Details
What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?
Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?
su li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include Directors & senior managers wen de yong , senior management bao qin gui , and senior management Mei Jing Ping .
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary
Over the past 18 months, su li made no insider transaction in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196). Other recent insider transactions involving Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) include a net sale of 110,000 shares made by Yao Fang , a net sale of 0 shares made by wen de yong , and a net sale of 0 shares made by Guan Xiao Hui .
In summary, during the past 3 months, insiders sold 110,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 110,000 shares. During the past 18 months, 110,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
su li Mailing Address
Above is the net worth, insider trading, and ownership report for su li. Currently GuruFocus does not have mailing address information for su li.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
